Antithrombin III (AT) and recombinant tissue plasminogen activator (R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation (DIC) in the neonatal pig

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  Davis Jackson, Rachel ^a   Correa, Hernan ^b   Horswell, Ronald ^a   Sadowska Krowicka, Halina ^b   McDonough, Kathleen ^b   Debata, Chittaranjan ^b   Gardner, Renee' ^b   Penn, Duna ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTITHROMBIN III; DOBUTAMINE; DOPAMINE; ENDOTOXIN; FIBRINOGEN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSISTED VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN BLOOD LEVEL; FLUID THERAPY; HEMATOCRIT; HYPOTENSION; NEWBORN; NONHUMAN; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SWINE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 33747035271     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-7     Document Type: Article

References (28)

1. Levi MJE, van der Poll T: New Treatment strategies for disseminated intravascular coagulation based on current understanding of pathophysiology. Annals of Medicine 2004:41-49.
2. Tapper HHHB: Modulation of hemostatic mechanisms in bacterial infectious diseases. 2000, 96(7):2329-2337.
3. Esmon CT. Blood Coagulation, in Nathan and Oski's Hematology of Infancy and Childhood. Edited by: Nathan DGaC, Stuart H. W.B Saunders Co: Philadelphia; 1998:1531-1557.
4. de Jonge ELM, Christiaan SP, van Deventer SJH: Current Drug Treatment Strategies for Disseminated Intravascular Coagulation. Drugs 1998, 55(6):767-777.
5. Edstrom C, Christensen RD, Andrew M: Developmental Aspects of Blood Hemostasis and Disorders of Coagulation and Fibrinolysis in the Neonatal Period, in Hematologic Problems of the Neonate. Edited by: Christensen RD. W.B. Saunders Co.: Philadelphia; 2000:239, 242, 243-257.
6. Kreuz WVA, Fischer D, Schlosser R, Volk WR, Ettingshausen LE: Neonatal Sepsis. A Challenge in Hemostaseology. Seminars in Thrombosis and Hemostasis 1999, 25(6):531-534.
7. Andrew MPB, Johnston M: Development of the coagulation system in the healthy premature infant. Blood Coagulation and Fibrinolysis 1988, 72:1651.
8. Fanaroff AAMR: The Immune System/The Blood and Hematopoietic System, in Neonatal-Perinatal Medicine. In Diseases of the fetus and infant Edited by: Fanaroff AAMR. Mosby: St. Louis, MO; 1997:717-1244.
9. Lilleyman JHI, Blanchette V: Pediatric Hematology, in Pediatric Hematology. Saunders 1999:631-633.
10. Gross SJFH: Controlled study of treatment of disseminated intravascular coagulation in the neonate. The Journal of Pediatrics 1982, 100(3):445-448.
11. Munoz MCMR, Hermida J, Orbe J, Paramo, JA, Rocha E: Effect of the administration of recombinant hirudin and/or tissue plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits. British Journal of Haematology 1999, 105:117-122.
12. Swindle M, Hand MS, Phillips RW, Fettman MJ, Chandrasena LG: Porcine Model in surgical research/Endotoxemic swine as a model for the metabolic response to sepsis, in Swine in Biomedical Research. Edited by: Tumbleson M. Plenum Publishing Corp: New York, 1986:235-453.
13. Massicotte P, Mitchell L, Andrew M: A comparative study of coagulation systems in newborn animals. Pediatr Res 1986, 20(10):961-5.
14. Federation of American Societies for Experimental Biology and American Physiological Society (1887-). Federation proceedings, Federation of American Societies for Experimental Biology. [Bethesda, Md., etc.]:46v.
15. Velik-Salchner C, Schnurer C, Fries D, Mussigang PR, Moser PL, Streif W, Kolbitsch C, Lorenz IH: Normal values for thrombelastography (ROTEM(R)) and selected coagulation parameters in porcine blood. Thromb Res 2006, 117(5):597-602.
16. Rivard GEDM, Farrell C, Schwarz HP: Treatment of purpura fulminans in meningococcemia with protein C concentrate. Journal of Pediatrics 1995:646-651.
17. Ettingshausen CEVA, Beeg T, Schneider W, Jager G, Kreuz W: Replacement Therapy with Protein C Concentrate in Infants and Adolescents with Meningococcal Sepsis and Purpura Fulminans. Seminars in Thrombosis and Hemostasis 1999, 25(6):537-541.
18. Hanada TAT, Takita H: Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children. The American Journal of Pediatric Hematology/Oncology 1985, 7(1):3-8.
19. Favier RDA, Belhocine R, Ankri A, Costil J, de Moerloose P: Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child. Hematology and Cell Therapy 1998, 40:67-70.
20. Zenz WMW, Gallistl S, Zobel G, Grubbauer HM: Recombinant Tissue Plasminogen Activator Treatment in Two Infants With Fulminant Meningococcemia. Pediatrics 1995, 96(1):144-147.
21. Dickneite GLB: Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol 1999:1566-1572.
22. Kries RVSH, Gobel U: Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. European Journal of Pediatrics 1985, 144:191-194.
23. Fourrier FJM, Tournoys A, Gosset P, Mangalaboyi J, Chopin C: Effects of a combined Antithrombin III and Protein C supplementation in porcine acute endotoxic shock. Shock 1998, 10(5):364-370.
24. Auito LTBS, Cohen PS, Boxer RA: Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Critical Care Medicine 1997, 25(6):1079-1082.
25. Taylor FBCA Jr, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE, Protein C: Prevents the Coagulopathic and Lethal Effects of Escherichia coli Infusion in the Baboon. Journal of Clinical Investigations 1987, 79:918-925.
26. Kessler CMTZ, Jacobs HM, Szymanski LM: The Suprapharmacologic Dosing of Antithrombin Concentrate for Staphylococcus Aureus-Induced Disseminated Intravascular Coagulation in Guinea Pigs: Substantial Reduction in Mortality and Morbidity. Blood Coagulation and Fibrinolysis 1997, 89(12):4393-4401.
27. Dickneite G, Kroez M: Treatment of porcine sepsis with high-dose antithrombin III reduces tissue edema and effusion but does not increase risk of bleeding. Blood Coagulation and Fibrinolysis 2001, 12(6):459-467.
28. Schmidt BMRB, Ofosu F, Brooker L, Hirsh J, Andrew M: Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis. Thrombosis and Haemostasis 1988, 60(2):289-292.